Effect of formoterol, tiotropium, and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study

Respiratory Medicine
F di MarcoS Centanni

Abstract

The aim of our study was to evaluate the pharmacodynamic effects of 1-day treatment with formoterol, tiotropium and their combination in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Twenty-one (19 males, mean age 72+/-8 years, mean FEV1 38+/-14% of predicted values) patients with mild to moderate AECOPD were enrolled. Patients received formoterol (12 microg deliver via Modulite b.i.d.), tiotropium (18 microg dry powder capsules delivered via HandiHaler once daily), and their combination, in randomized sequence. Serial measurements of FEV1, FVC, IC, SpO2 and HR were performed over 24h. Formoterol, tiotropium, and their combination significantly improved the area under curves (AUCs) for FEV1, FVC and IC over 12 and 24h. The mean FEV1, FVC and IC AUC(0-12h) and AUC(0-24h) after formoterol and tiotropium combination were significantly higher than formoterol and tiotropium alone, whereas the differences between the two single drugs were not statistically significant. Formoterol, either alone or in combination with tiotropium, elicited a significantly faster onset of action, and combination elicited a greater maximum bronchodilation than both single drugs in terms of FEV1 and FVC. After 24h the ...Continue Reading

References

Feb 1, 1987·Annals of Internal Medicine·N R AnthonisenN A Nelson
Apr 14, 2000·American Journal of Respiratory and Critical Care Medicine·M R LittnerT J Witek
May 12, 2000·American Journal of Respiratory and Critical Care Medicine·T A SeemungalJ A Wedzicha
May 1, 2001·Journal of Advanced Nursing·E R Van TeijlingenW Graham
Aug 9, 2001·The European Respiratory Journal·S GompertzR A Stockley
Sep 11, 2001·American Journal of Respiratory and Critical Care Medicine·D E O'DonnellK A Webb
Feb 7, 2003·The European Respiratory Journal·F Di MarcoS Centanni
Dec 4, 2003·Pulmonary Pharmacology & Therapeutics·Mario CazzolaStefano Centanni
May 5, 2004·Pulmonary Pharmacology & Therapeutics·M CazzolaS Centanni
Jun 29, 2004·The European Respiratory Journal·D E O'DonnellH Magnussen
Aug 2, 2005·The European Respiratory Journal·J A van NoordP J G Cornelissen
Nov 2, 2005·Expert Opinion on Pharmacotherapy·Stefano Centanni, Fabiano Di Marco

❮ Previous
Next ❯

Citations

Aug 29, 2014·Annals of the American Thoracic Society·Peter K LindenauerMihaela S Stefan
Nov 30, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Jane E Scullion
Apr 7, 2010·International Journal of Chronic Obstructive Pulmonary Disease·Donald P Tashkin
May 9, 2013·Respiratory Research·Donald P Tashkin, Gary T Ferguson
May 16, 2009·Expert Opinion on Therapeutic Patents·Nicholas C Ray, Lilian Alcaraz
Jul 1, 2008·Expert Review of Clinical Immunology·Jeffrey B Rubins
Jun 10, 2009·Expert Opinion on Drug Safety·Pierachille Santus, Fabiano Di Marco
Feb 21, 2009·COPD·Donald P TashkinSantosh T Varghese
Mar 10, 2016·Archives of Gerontology and Geriatrics·Alice LaudisioRaffaele Antonelli Incalzi
Aug 28, 2007·Clinics in Chest Medicine·Nicola A Hanania, Amir Sharafkhaneh
Mar 17, 2007·Respiratory Medicine·Mario CazzolaNicola A Hanania
Aug 9, 2008·Respiratory Medicine·Mario CazzolaStephen Rennard
Sep 23, 2008·Respiratory Medicine·Claus VogelmeierJackie Thirlwell
Aug 24, 2016·Expert Review of Respiratory Medicine·Dejan RadovanovicPierachille Santus
Sep 14, 2012·The Cochrane Database of Systematic Reviews·Jimmy ChongPhillippa Poole
Jun 26, 2015·Expert Review of Clinical Pharmacology·Andrea S Melani
Dec 19, 2019·Pharmacological Reviews·M G MateraM Cazzola
Jun 27, 2021·Archivos de bronconeumología·Juan José Soler-CataluñaUNKNOWN en representación del grupo de trabajo de GesEPOC 2021

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.